USD 8.98 billion
Antibiotic Resistance Market Size, Share, Growth Analysis, By Drug-class(Beta-lactams, macrolides, tetracyclines, fluoroquinolones), By Pathogen(Gram-negative bacteria, gram-positive bacteria), By Disease(Respiratory infections, urinary tract infections, bloodstream infections, and others), By Region - Industry Forecast 2025-2032
Report ID:
SQMIG35H2182 |
Region:
Global |
Published Date: April, 2024
Pages:
219
|Tables:
92
|Figures:
76
Antibiotic Resistance Market Insights
Antibiotic Resistance Market size was valued at USD 10.16 Billion in 2023 and is poised to grow from USD 11.5 Billion in 2024 to USD 31 Billion by 2032, growing at a CAGR of 13.19% during the forecast period (2025-2032).
The global antibiotic resistance market is experiencing significant growth globally. Our report contains detailed information on the value chain analysis for the Antibiotic Resistance market, which manufacturers can use to gain a competitive edge during the projected period. Antibiotic resistance has become a global health crisis, posing a serious threat to the effectiveness of standard treatments for infectious diseases. The overuse and misuse of antibiotics are major factors leading to the development of resistance.
Inadequate infection prevention and control measures in healthcare settings also contribute to the spread of resistant bacteria. Additionally, the lack of new antibiotics in development is a significant concern. This scarcity of new drugs limits treatment options and exacerbates the problem of antibiotic resistance. Governments, healthcare organizations, and pharmaceutical companies are increasingly recognizing the urgent need to address this issue.
Public-private partnerships for antibiotic development are being encouraged to spur innovation. Moreover, the implementation of antibiotic stewardship programs, which promote optimal antibiotic use and reduce resistance, is gaining traction. Awareness campaigns and educational initiatives aimed at healthcare professionals and the general public are being conducted to improve antibiotic prescribing practices and increase knowledge about antibiotic resistance.
Technological advancements, such as genomics and proteomics, are also being utilized to better understand the mechanisms of antibiotic resistance and develop novel treatment strategies. Alternative treatment options, including phage therapy and immunotherapy, are emerging as potential solutions to combat antibiotic resistance. The antibiotic resistance market presents both challenges and opportunities, and concerted efforts are required to mitigate the growing threat of antibiotic resistance and ensure effective treatment of bacterial infections in the future.
US Antibiotic Resistance Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2025-2032
Global Market Size
Largest Segment
Beta-Lactams
Fastest Growth
Beta-Lactams
Growth Rate
13.19% CAGR
Global Antibiotic Resistance Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Antibiotic Resistance Market Segmental Analysis
The global antibiotic resistance market can be segmented based on drug-class, pathogen, disease type, and region. Based on drug class, the market can be divided into beta-lactams, macrolides, tetracyclines, fluoroquinolones, and others. Based on pathogens, the market can be categorized into gram-negative bacteria, gram-positive bacteria, and others. Based on disease types, the market can be categorized into respiratory infections, urinary tract infections, bloodstream infections, and others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Analysis By Drug-class
Beta-lactams segment holds the largest market share in the antibiotic resistance market. Beta-lactam antibiotics, including penicillins and cephalosporins, are widely used for the treatment of various bacterial infections. They inhibit bacterial cell wall synthesis, but over time, bacteria have developed mechanisms to overcome the effects of these antibiotics, leading to the emergence of resistance. The extensive use of beta-lactams in both community and healthcare settings has contributed to the development and spread of antibiotic-resistant bacteria. The high market share of beta-lactams can be attributed to their broad spectrum of activity, efficacy against many common bacterial pathogens, and relatively lower cost compared to other drug classes.
On the other hand, the fastest-growing segment in the antibiotic resistance market is the fluoroquinolones class. Fluoroquinolones are broad-spectrum antibiotics that inhibit bacterial DNA synthesis. They are commonly used to treat respiratory, urinary tract, and gastrointestinal infections. Bacterial strains with mutations in their DNA gyrase and topoisomerase genes have become resistant to fluoroquinolones, making these antibiotics less effective. Despite the challenges posed by resistance, fluoroquinolones remain popular due to their potency and broad coverage against a wide range of bacterial pathogens.
Analysis By Disease Type
The largest segment in the antibiotic resistance market is respiratory infections. Respiratory infections encompass a wide range of conditions, including pneumonia, bronchitis, and sinusitis, among others. These infections are commonly caused by bacterial pathogens such as Streptococcus pneumoniae, Haemophilus influenzae, and Mycoplasma pneumoniae. Antibiotic resistance in respiratory pathogens limits the effectiveness of standard antibiotics, leading to treatment failures and prolonged illness. This has fueled the need for alternative treatment options and the development of new antibiotics targeting respiratory pathogens.
The fastest-growing segment in the antibiotic resistance market is urinary tract infections (UTIs). UTIs are one of the most common bacterial infections, affecting both men and women. The primary causative agents of UTIs are Escherichia coli, Klebsiella pneumoniae, and Enterococcus faecalis. Resistance mechanisms, such as extended-spectrum beta-lactamases (ESBLs) and carbapenemases, have rendered many antibiotics ineffective. The increasing prevalence of multidrug-resistant UTIs has prompted the development of new treatment strategies, including combination therapies and the exploration of novel antibiotics.
Global Antibiotic Resistance Market By Drug Class
To get detailed analysis on other segments, Request For Free Sample Report
Antibiotic Resistance Market Regional Insights
The largest market region in the antibiotic resistance market is North America. North America dominates the market due to several factors. Firstly, the region has a high prevalence of antibiotic resistance, with a significant burden of antibiotic-resistant infections reported. This is attributed to factors such as the overuse and misuse of antibiotics, both in healthcare settings and the community. Secondly, North America has a well-established healthcare infrastructure, enabling effective diagnosis, surveillance, and treatment of antibiotic-resistant infections. The region also exhibits robust research and development activities focused on developing new antibiotics and alternative treatment options. Additionally, government initiatives and public-private partnerships in North America have played a crucial role in addressing antibiotic resistance through the implementation of antibiotic stewardship programs and raising awareness about appropriate antibiotic use.
On the other hand, the fastest-growing region in the antibiotic resistance market is Asia Pacific. The Asia Pacific region is witnessing a rapid increase in antibiotic resistance due to several factors. Firstly, the region has a high burden of infectious diseases, leading to significant antibiotic use. However, the inappropriate use of antibiotics, including overuse and misuse, has contributed to the emergence and spread of antibiotic-resistant bacteria. Poor infection prevention and control practices in healthcare settings further exacerbate the problem. Moreover, the Asia Pacific region has a dense population and a high burden of antibiotic-resistant pathogens, making it a hotspot for the spread of resistance. The growing awareness about antibiotic resistance and the need for effective interventions are driving efforts to combat the issue in the region.
Global Antibiotic Resistance Market By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Antibiotic Resistance Market Dynamics
Drivers
Increasing Prevalence Of Antibiotic-Resistant Infections
- The growing incidence of infections caused by antibiotic-resistant bacteria necessitates the development of effective treatment options. As traditional antibiotics become less effective, there is a heightened demand for innovative antibiotics and alternative therapies to combat resistant strains. This driver fuels the research and development activities in the field, leading to the discovery of new drugs and treatment approaches to address antibiotic resistance. Additionally, the rising public awareness about the serious consequences of antibiotic resistance has spurred governments, healthcare organizations, and pharmaceutical companies to allocate resources and invest in initiatives aimed at combating the issue.
Restraints
Lack Of New Antibiotics In Development
- The pipeline for novel antibiotics is relatively limited compared to the growing threat of antibiotic resistance. The development of new antibiotics is a complex and challenging process that requires significant investment, time, and expertise. However, factors such as the high cost of research and development, regulatory challenges, and the low return on investment have contributed to a decline in antibiotic development. The restraint of limited new antibiotics hinders the ability to effectively treat antibiotic-resistant infections and underscores the urgent need for increased efforts and incentives to stimulate the development of novel antibiotics.
Request Free Customization of this report to help us to meet your business objectives.
Antibiotic Resistance Market Competitive Landscape
The competitive landscape of the antibiotic resistance market is characterized by a mix of established pharmaceutical companies, emerging biotechnology firms, and research institutions actively engaged in addressing the global challenge of antibiotic resistance. Key players in the market are involved in various activities such as research and development, strategic collaborations, product launches, and mergers and acquisitions to strengthen their market position and drive innovation. With the growing demand for health conciousness and accuracy, the competition among these players intensifies, leading to continuous advancements and improvements in the market offerings.
Top Player’s Company Profile
- Pfizer Inc. (US)
- Johnson & Johnson (US)
- Achaogen Inc. (US)
- Tetraphase Pharmaceuticals, Inc. (US)
- Paratek Pharmaceuticals, Inc. (US)
- Melinta Therapeutics, Inc. (US)
- Cipla Ltd. (India)
- Roche Holding AG (Switzerland)
- Sanofi (France)
- Eli Lilly and Company (US)
- Bayer AG (Germany)
- Cubist Pharmaceuticals, Inc. (US)
- Allergan plc (Ireland)
- AstraZeneca plc (UK)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Mylan N.V. (US)
- Basilea Pharmaceutica Ltd. (Switzerland)
Recent Developments
- In June 2023, BSI, the business improvement and standards company, launched a new global Minimized Risk of Antimicrobial Resistance (AMR) certification designed to promote and attest to the responsible manufacturing of antibiotics in the global supply chain.
- In November 2022, Apollo announced the launch of an Antimicrobial Stewardship Programme (Apollo ASP). The programme will sensitize care providers on Antimicrobial Resistance (AMR), an issue leading to a public health problem.
- In April 2022, Johnson & Johnson announced the opening of the J&J Satellite Center for Global Health Discovery (Satellite Center) at the University of Cape Town's Holistic Drug Discovery and Development (H3D).
Antibiotic Resistance Key Market Trends
- Increasing focus on alternative treatment options: With the rise in antibiotic resistance, there is a growing realization that solely relying on conventional antibiotics may not be sufficient to combat the challenge. As a result, there is a shift towards exploring and developing alternative approaches to address bacterial infections. One notable trend is the advancement of phage therapy, which involves using bacteriophages (viruses that infect and kill bacteria) to target and eliminate antibiotic-resistant bacteria. Phage therapy offers a potential solution to overcome antibiotic resistance by specifically targeting the pathogenic bacteria without harming the beneficial microbiota.
Antibiotic Resistance Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our analyses, The Antibiotic Resistance market is poised for significant growth in the coming years, driven by various factors and offering substantial future scope. The antibiotic resistance market is a critical and rapidly evolving field that encompasses the global challenge of combating bacterial infections that have become resistant to conventional antibiotics. With the increasing prevalence of antibiotic-resistant infections, the market's future scope is promising, driven by the urgent need for innovative solutions. The most significant driving factor in the market is the rising incidence of antibiotic-resistant pathogens, which has led to a heightened demand for effective treatment options. Respiratory infections emerge as the largest segment, heavily impacted by antibiotic resistance, while urinary tract infections (UTIs) represent the fastest-growing segment, driven by the escalating incidence of multidrug-resistant strains. North America dominates the market, leveraging its robust healthcare infrastructure and extensive research and development activities. Looking ahead, the future of the antibiotic resistance market lies in the development of new antibiotics, alternative therapies, and strategies for responsible antibiotic use. Collaborations among industry players, academic institutions, and government organizations will continue to be crucial in addressing this global healthcare challenge. Ultimately, the collective efforts in research, innovation, and global collaboration are essential for ensuring effective treatment options and combating the growing threat of antibiotic resistance.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 10.16 Billion |
| Market size value in 2032 | USD 31 Billion |
| Growth Rate | 13.19% |
| Base year | 2024 |
| Forecast period | 2025-2032 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Antibiotic Resistance Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Antibiotic Resistance Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Antibiotic Resistance Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Antibiotic Resistance Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Antibiotic Resistance Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Antibiotic Resistance Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
